V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011523 | 310008126 | 1.6 | 73.2 | Palliative (P) | null | 2017-01-03 | Docetaxel 75mg/m2 (21 day) | null | null | 310019388 | DOCETAXEL |
| 310011524 | 310004933 | 1.68 | 62.3 | Curative (C) | 2016-09-23 | 2016-09-24 | Cyclophosphamide High Dose | 02 | N | 310019457 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011525 | 310004937 | 1.55 | 0 | Curative (C) | 2014-04-02 | 2014-04-10 | Methotrexate intrathecal | N | N | 310019463 | METHOTREXATE INTRATHECAL |
| 310011526 | 310004947 | 1.51 | 74 | Disease modification (D) | 2015-08-29 | 2015-09-03 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | N | 310019473 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310011527 | 310004952 | 1.75 | 104.4 | Palliative (P) | 2018-11-19 | 2018-12-05 | Ipilimumab | N | N | 310019477 | IPILIMUMAB |
| 310011528 | 310004956 | 1.7 | 68.6 | Palliative (P) | 2018-03-10 | 2018-07-22 | GDP | 1 | N | 310019507 | GDP |
| 310011529 | 310008146 | 1.59 | null | Curative (C) | 2018-03-12 | 2018-03-12 | GDP | N | N | 310019511 | GDP |
| 310011531 | 310010754 | 1.58 | 60.5 | Palliative (P) | 2017-03-07 | 2017-11-22 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310019551 | BEXAROTENE |
| 310011532 | 310004971 | 1.55 | 77 | null | 2016-03-12 | 2016-07-27 | Cisplatin + Radiotherapy | N | N | 310019558 | CISPLATIN + RT |
| 310011533 | 310004982 | 0 | 59.9 | Palliative (P) | 2014-07-12 | 2014-07-26 | Etoposide oral | 2 | N | 310019583 | ETOPOSIDE |
| 310011534 | 310010756 | 1.69 | null | Curative (C) | 2017-12-07 | 2018-02-15 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | N | 310019585 | CARBOPLATIN + ETOPOSIDE |
| 310011535 | 310011734 | 1.69 | 59 | Neo-adjuvant (N) | null | 2016-01-19 | ALL UKALL2011 Cap Int Maint C PAsp | 2 | null | 310019617 | CARBOPLATIN + ETOPOSIDE |
| 310011536 | 310008171 | 1.74 | 79.6 | Not known (9) | 2015-05-23 | 2015-05-29 | CAV | N | N | 310019675 | METHOTREXATE HIGH DOSE |
| 310011537 | 310004999 | 1.62 | 76.6 | Palliative (P) | 2014-07-04 | 2015-01-23 | LANREOTIDE | 02 | N | 310019677 | OXALIPLATIN + MDG |
| 310011539 | 310005012 | null | 50.7 | Palliative (P) | 2017-05-21 | 2017-06-01 | EDP | null | null | 310019697 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310011540 | 310005025 | 1.68 | 69.2 | Not known (9) | 2014-04-04 | 2015-04-15 | PLUTO TRIAL | Y | null | 310019750 | ECHELON-2 TRIAL |
| 310011541 | 310011284 | 1.73 | 77.6 | Palliative (P) | 2015-08-21 | 2016-02-26 | Capecitabine + Cisplatin | N | N | 310019847 | TEMOZOLOMIDE |
| 310011542 | 310005054 | null | 88.2 | Palliative (P) | 2016-01-25 | 2017-06-19 | Cytarabine HD + Methotrexate HD | N | N | 310019894 | BEP |
| 310011543 | 310005082 | 1.76 | 100.8 | Curative (C) | 2019-08-11 | 2019-09-08 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | N | N | 310019991 | PEG INTERFERON |
| 310011544 | 310009885 | 1.59 | 96.7 | Palliative (P) | 2019-04-16 | 2019-04-17 | MITOMYCIN | N | N | 310020087 | IVE + METHOTREXATE |
| 310011545 | 310005111 | 1.72 | 76 | Palliative (P) | 2017-01-12 | 2017-01-26 | METHOTREXATE | 02 | N | 310020124 | VEDEX |
| 310011546 | 310005124 | 1.85 | 102.8 | Palliative (P) | 2016-09-06 | 2016-09-14 | Oxaliplatin + Modified de Gramont | 2 | N | 310020170 | TRABECTEDIN |
| 310011547 | 310009904 | 1.76 | null | Palliative (P) | 2014-02-23 | 2014-02-24 | DHAP - R | N | N | 310023229 | PMITCEBO |
| 310011548 | 310005193 | 1.79 | null | Palliative (P) | 2017-12-06 | 2017-12-06 | INTERFERON | 02 | N | 310023631 | DOXORUBICIN |
| 310011549 | 310005231 | 1.92 | 83.8 | Curative (C) | 2013-08-02 | 2014-01-11 | Gemcitabine + Oxaliplatin | 01 | N | 310024290 | DOXORUBICIN |
| 310011550 | 310008298 | null | 77.6 | Curative (C) | null | 2016-11-16 | Methotrexate Intermed dose (1g/m2) | 02 | N | 310024324 | VINCRISTINE |
| 310011551 | 310005236 | 1.64 | null | Palliative (P) | 2014-11-30 | 2014-12-01 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 310024355 | DOXORUBICIN |
| 310011552 | 310005240 | 1.57 | 75.8 | Palliative (P) | 2017-02-16 | 2017-08-30 | TRASTUZUMAB | N | N | 310024441 | ATG |
| 310011553 | 310005250 | null | 0 | null | 2018-04-12 | 2018-04-14 | Imatinib 400mg | N | N | 310024543 | GEMCITABINE + OXALIPLATIN |
| 310011555 | 310005264 | 1.57 | 78 | Curative (C) | null | 2019-02-08 | BEVACIZUMAB + CARBO | null | null | 310024633 | BENDAMUSTINE |
| 310011556 | 310005274 | 1.76 | null | Curative (C) | null | 2017-04-25 | Hydroxycarbamide | N | null | 310024826 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310011557 | 310005276 | 1.6 | 87 | Palliative (P) | 2019-01-13 | 2019-02-25 | ICE-R (Cycle 2 onwards) | N | N | 310024828 | PEMETREXED |
| 310011558 | 310010814 | null | 86.9 | Curative (C) | 2015-11-24 | 2015-12-02 | Hydroxycarbamide | N | N | 310024934 | HYDROXYCARBAMIDE |
| 310011559 | 310005294 | 1.55 | 49 | Palliative (P) | 2014-10-04 | 2015-11-22 | Topotecan IV 7 day | 02 | N | 310024937 | TRASTUZUMAB |
| 310011560 | 310005295 | 1.57 | 62 | Curative (C) | 2018-11-01 | 2018-12-11 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 310024973 | IMATINIB |
| 310011562 | 310009952 | 1.53 | 50 | Palliative (P) | 2019-02-23 | 2019-03-15 | Methotrexate High Dose (3g/m2) | 2 | N | 310025187 | IMATINIB |
| 310011563 | 310005329 | 1.7 | 56.6 | Not known (9) | 2013-10-13 | 2014-04-15 | BCG Intravesical | 2 | N | 310025291 | INTERFERON |
| 310011564 | 310005339 | 1.67 | null | Palliative (P) | 2016-07-23 | 2016-07-30 | ICE (no GCSF) | N | N | 310025341 | CISPLATIN + ETOPOSIDE |
| 310011565 | 310005343 | 1.82 | 71.35 | Palliative (P) | null | 2016-12-23 | CTD Attenuated (Thalidomide 100mg) | Y | N | 310025360 | CVD |
| 310011566 | 310009960 | 1.85 | 64 | Adjuvant (A) | 2016-08-15 | 2016-09-04 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE | 02 | N | 310025414 | SUNITINIB |
| 310011567 | 310005365 | 1.74 | 73.7 | Palliative (P) | 2016-12-21 | 2016-12-21 | CARBOPLATIN + PACLITAXEL + RT | N | Y | 310025608 | DOXORUBICIN |
| 310011568 | 310005384 | 1.65 | null | Disease modification (D) | 2016-10-16 | 2016-10-16 | Cytarabine High Dose | null | null | 310025710 | ICON TRIAL |
| 310011569 | 310005391 | null | null | Disease modification (D) | 2015-07-10 | 2015-07-12 | Capecitabine | null | null | 310025719 | GEMCITABINE + OXALIPLATIN |
| 310011571 | 310005406 | 1.72 | 0 | Palliative (P) | 2019-04-21 | 2019-04-21 | R GCVP | null | null | 310000433 | GEMCITABINE + VINORELBINE |
| 310011572 | 310008382 | 1.84 | 59.3 | Adjuvant (A) | 2017-09-16 | 2018-07-22 | Carboplatin + Docetaxel | 02 | N | 310000469 | CETUXIMAB |
| 310011573 | 310005416 | 1.61 | 58.6 | Curative (C) | null | 2018-12-18 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 310000647 | DHAP |
| 310011574 | 310005429 | 1.61 | 58.2 | Palliative (P) | 2017-09-30 | 2017-10-12 | Azacitidine | null | null | 310001330 | METHOTREXATE |
| 310011575 | 310005439 | 1.53 | 53.6 | Palliative (P) | 2017-05-20 | 2017-11-01 | ICE (no GCSF) | 02 | N | 310001682 | OLAPARIB |
| 310011576 | 310005443 | 1.84 | 71.6 | Curative (C) | 2016-04-12 | 2016-04-13 | Ifosfamide | N | N | 310001938 | DACARBAZINE |
| 310011577 | 310005448 | 1.7 | 74.6 | Curative (C) | null | 2015-12-23 | Eribulin | 02 | Y | 310002316 | CAPECITABINE |